Regarding IL-23, dendritic cells derived from MS patients release higher quantities of IL-23 and exhibit elevated levels of IL-23p19 mRNA, resulting in increased IL-17 production by Th17 cells [136]. This evidence concerns the gene IL17A and myeloid sarcoma.